ATE121298T1 - Verfahren zur herstellung eines antikaries- impfstoffes aus streptococcus mutans und impfzusammensetzung gegen karies in form von nasentropfen. - Google Patents

Verfahren zur herstellung eines antikaries- impfstoffes aus streptococcus mutans und impfzusammensetzung gegen karies in form von nasentropfen.

Info

Publication number
ATE121298T1
ATE121298T1 AT90110144T AT90110144T ATE121298T1 AT E121298 T1 ATE121298 T1 AT E121298T1 AT 90110144 T AT90110144 T AT 90110144T AT 90110144 T AT90110144 T AT 90110144T AT E121298 T1 ATE121298 T1 AT E121298T1
Authority
AT
Austria
Prior art keywords
protein antigen
vaccine
streptococcus mutans
caries
pac
Prior art date
Application number
AT90110144T
Other languages
English (en)
Inventor
Toshihiko Koga
Nobuo Okahashi
Ichiro Takahashi
Koji Shibuya
Hirotaka Ohta
Original Assignee
Lion Corp
Nat Inst Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP20770089A external-priority patent/JP2707333B2/ja
Application filed by Lion Corp, Nat Inst Health filed Critical Lion Corp
Application granted granted Critical
Publication of ATE121298T1 publication Critical patent/ATE121298T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90110144T 1989-05-29 1990-05-29 Verfahren zur herstellung eines antikaries- impfstoffes aus streptococcus mutans und impfzusammensetzung gegen karies in form von nasentropfen. ATE121298T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13702589 1989-05-29
JP20770089A JP2707333B2 (ja) 1989-08-09 1989-08-09 点鼻用う蝕予防ワクチン組成物

Publications (1)

Publication Number Publication Date
ATE121298T1 true ATE121298T1 (de) 1995-05-15

Family

ID=26470457

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90110144T ATE121298T1 (de) 1989-05-29 1990-05-29 Verfahren zur herstellung eines antikaries- impfstoffes aus streptococcus mutans und impfzusammensetzung gegen karies in form von nasentropfen.

Country Status (6)

Country Link
US (1) US5352450A (de)
EP (1) EP0400569B1 (de)
AT (1) ATE121298T1 (de)
AU (1) AU626049B2 (de)
DE (1) DE69018702T2 (de)
NO (1) NO902352L (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9602280D0 (sv) * 1996-06-10 1996-06-10 Pharmatrix Ab Immunstimulerande lipidformulering
US6964760B2 (en) * 1997-06-10 2005-11-15 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
US20060198793A1 (en) * 1997-06-10 2006-09-07 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
US5932469A (en) * 1997-06-10 1999-08-03 University Of Florida Antimicrobial polypeptide, nucleic acid, and methods of use
US6475771B1 (en) 1997-06-10 2002-11-05 University Of Florida Research Foundation Antimicrobial polypeptides and methods of use
US6231857B1 (en) 1998-09-28 2001-05-15 The Regents Of The University Of California Antibodies to S. mutans and uses thereof
TWI228420B (en) 2001-05-30 2005-03-01 Smithkline Beecham Pharma Gmbh Novel vaccine composition
JP4056837B2 (ja) * 2002-09-19 2008-03-05 株式会社ジーシー う蝕リスク検査方法
US7875598B2 (en) * 2004-03-04 2011-01-25 The Regents Of The University Of California Compositions useful for the treatment of microbial infections
WO2008030988A2 (en) 2006-09-06 2008-03-13 The Regents Of The University Of California Selectively targeted antimicrobial peptides and the use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4962624A (de) * 1972-10-17 1974-06-18
ZA794413B (en) * 1978-09-01 1980-08-27 Us Government Protection against dental caries
JPS56501364A (de) * 1979-10-18 1981-09-24
GB2060647B (en) * 1979-10-18 1983-04-13 Russell M W Antigens ex streptococcus mutans
JPS57114526A (en) * 1981-01-07 1982-07-16 Dainippon Pharmaceut Co Ltd Antigen derived from tooth cariogenic bacterium
WO1982004396A1 (en) * 1981-06-19 1982-12-23 Russell Roy Robert Baird Protection against dental caries
JPS58164518A (ja) * 1982-03-25 1983-09-29 Kitasato Inst:The 虫歯予防用ワクチン
JPS6064930A (ja) * 1983-09-20 1985-04-13 Kitasato Inst:The 虫歯用ワクチン
US4693888A (en) * 1983-08-11 1987-09-15 Lion Corporation Caries-preventive composition
JPS6038329A (ja) * 1983-08-11 1985-02-27 Lion Corp う蝕予防剤
JPH0641424B2 (ja) * 1984-11-06 1994-06-01 ライオン株式会社 う蝕予防剤
JPH0753669B2 (ja) * 1985-11-25 1995-06-07 株式会社ゲン・コーポレーション 鶏卵からの特異的抗体含有材料およびその製造方法と用途
GB8704647D0 (en) * 1987-02-27 1987-04-01 Guy S & St Thomas S Hospitals Vaccine

Also Published As

Publication number Publication date
DE69018702D1 (de) 1995-05-24
AU626049B2 (en) 1992-07-23
AU5597990A (en) 1990-11-29
DE69018702T2 (de) 1995-10-19
NO902352L (no) 1990-11-30
NO902352D0 (no) 1990-05-28
EP0400569B1 (de) 1995-04-19
EP0400569A2 (de) 1990-12-05
EP0400569A3 (de) 1991-06-05
US5352450A (en) 1994-10-04

Similar Documents

Publication Publication Date Title
AU4951196A (en) Vaccines for plague
DE3681466D1 (de) Insulin-receptor, seine reinigung, seine herstellung in rekombinanten zellen, dna hierfuer, antikoerper gegen den insulin-receptor und deren herstellung, sowie pharmazeutische zusammensetzungen, die diese antikoerper enthalten.
JP2004002463A (ja) インターロイキン含有安定ワクチン組成物
ATA164884A (de) Verfahren zur herstellung von festen, zweiphasigen nifedipinhaltigen arzneimittelzubereitungen
ATE140386T1 (de) Verfahren zur potenzierung einer immunreaktion sowie die dazugehörigen mittel
ATE195077T1 (de) Ein pharmazeutisches präparat zur topischen verabreichung von antigenen und/oder vakzinen an die schleimhäute von säugern
GB9207731D0 (en) Improvements in or relating to vaccines
NO913518L (no) Vaksiner for ikke typebestembar haemophilus influenzae.
DE69637642D1 (de) Und kombinierte zusammensetzungen und deren verwendung
CA2014033A1 (en) Compositions and treatments for pneumonia in animals
FI101632B1 (fi) Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä
HUT50048A (en) Process for producing streptococcus protein antigen and pharmaceutical compositions comprising same
ATE121298T1 (de) Verfahren zur herstellung eines antikaries- impfstoffes aus streptococcus mutans und impfzusammensetzung gegen karies in form von nasentropfen.
DE3877151D1 (de) Melphalan oder melphalanhydrochlorid enthaltende pharmazeutische formulierungen sowie melphalan und melphalanhydrochlorid und verfahren zu ihrer herstellung.
EP0342860A3 (de) Neues Protein, Sequenze mit enthaltendem Gene, Vektoren, Verfahren zur Herstellung und Verwendung
FI924457A0 (fi) Kompositioner och behandlingsfoerfarande foer lunginflammation i djur
DE69034264D1 (de) Verfahren zur Herstellung eines azellulären Impfstoffes der Bordetella pertussis Antigene enthält
ATE73349T1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
ATE218369T1 (de) Verfahren zur herstellung von immunoaktiven mittel und impfstoffe
FR2646776B1 (fr) Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
HUT52703A (en) Process for producing living vaccines of newcastle disease virus
DE59504643D1 (de) Neue phosphanoxide, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
Koga et al. Method for preparing vaccine for dental caries and vaccinal compositions for dental caries used as nasal drop
Ackermans New look about the vaccination against dental caries.
HUP9903529A2 (hu) Tokképző mikroorganizmusok által okozott betegségek elleni rekombináns vakcina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties